Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics

Chaired by globally renowned nuclear medicine expert Prof. Ken Herrmann, M.D. Other Board members James Cook, Jason Lewis, Ph.D., and Michael ...

Aligos Therapeutics Presents Positive Data at HEP-DART 2025

The complete 96-week and post-treatment follow up data from the Phase 1 monotherapy (NCT04536337) cohorts in subjects with chronic HBV infection show the continued potential of pevifoscorvir sodium to ...